Methotrexate-associated primary cutaneous CD30-positive cutaneous T-cell lymphoproliferative disorder
[摘要] Methotrexate (MTX) is a commonly used anti-metabolite agent. Increased risk of lymphoproliferative disorders (LPD) in patients with rheumatoid arthritis (RA) has been documented with the prolonged use of immunosuppressive medications such as MTX. This is
[发布日期] [发布机构]
[效力级别] [学科分类] 血液学
[关键词] Methotrexate;lymphoproliferative disorders [时效性]